BSE Live
Dec 31, 16:01Prev. Close
2725.15
Open Price
2729.75
Bid Price (Qty.)
2756.00 (2)
Offer Price (Qty.)
2770.25 (6)
NSE Live
Dec 31, 15:54Prev. Close
2726.90
Open Price
2726.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2768.90 (2)
| Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 05 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 11.80 | |
| Total Share Capital | 11.80 | |
| Reserves and Surplus | 85.80 | |
| Total Reserves and Surplus | 85.80 | |
| Total Shareholders Funds | 97.60 | |
| Minority Interest | 0.22 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 53.02 | |
| Deferred Tax Liabilities [Net] | 0.00 | |
| Other Long Term Liabilities | 0.00 | |
| Long Term Provisions | 0.00 | |
| Total Non-Current Liabilities | 53.02 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 43.92 | |
| Trade Payables | 22.05 | |
| Other Current Liabilities | 0.01 | |
| Short Term Provisions | 0.06 | |
| Total Current Liabilities | 66.05 | |
| Total Capital And Liabilities | 216.90 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 67.21 | |
| Intangible Assets | 3.70 | |
| Capital Work-In-Progress | 0.00 | |
| Fixed Assets | 70.91 | |
| Non-Current Investments | 0.01 | |
| Deferred Tax Assets [Net] | 13.55 | |
| Long Term Loans And Advances | 0.00 | |
| Other Non-Current Assets | 0.00 | |
| Total Non-Current Assets | 84.47 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 67.46 | |
| Trade Receivables | 53.14 | |
| Cash And Cash Equivalents | 2.81 | |
| Short Term Loans And Advances | 9.01 | |
| OtherCurrentAssets | 0.00 | |
| Total Current Assets | 132.42 | |
| Total Assets | 216.90 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 13.71 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 1.23 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.01 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 |
30.12.2025
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct